PureTech Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	252.47	280.64	191.08	149.87	465.71
Short-Term Investments	36.25	98.05	136.06	200.23	-
Cash & Short-Term Investments	288.72	378.69	327.14	350.1	465.71
Cash Growth	-23.76%	15.76%	-6.56%	-24.82%	15.31%
Accounts Receivable	1.76	1.52	2.38	12.32	3.59
Other Receivables	6.37	-	11.75	10.04	4.51
Receivables	8.13	1.52	14.12	22.36	23.22
Prepaid Expenses	6.58	4.4	4.31	11.62	10.76
Restricted Cash	-	1.64	1.63	2.12	2.12
Other Current Assets	1.6	-	-0	-0	-0
Total Current Assets	305.02	386.26	347.2	386.19	501.81
Property, Plant & Equipment	11.5	15.13	19.36	37.24	43.94
Long-Term Investments	217.43	200.17	325.63	277.54	397.18
Other Intangible Assets	0.6	0.6	0.91	0.83	0.99
Long-Term Accounts Receivable	-	-	-	0.84	1.29
Other Long-Term Assets	0.17	0.48	0.88	0.01	0.81
Total Assets	534.71	602.64	693.97	702.65	946.01
Accounts Payable	23.19	5.52	14.64	26.5	11.35
Accrued Expenses	-	20.58	29.47	26.32	22.01
Short-Term Debt	18.16	4.11	3.7	2.35	4.64
Current Portion of Long-Term Debt	-	6.44	-	5.16	0.86
Current Portion of Leases	3.58	3.58	3.39	4.97	3.95
Current Income Taxes Payable	1.21	0.08	-	0.06	0.06
Current Unearned Revenue	-	-	-	2.19	0.07
Other Current Liabilities	0.17	1.09	0.17	29.34	183.21
Total Current Liabilities	46.31	41.39	51.37	96.89	226.14
Long-Term Debt	170.42	136.78	110.16	10.24	14.26
Long-Term Leases	11.09	14.67	18.25	24.16	29.04
Long-Term Deferred Tax Liabilities	-	-	52.46	19.65	89.77
Other Long-Term Liabilities	1.22	1.86	3.5	4.13	2.66
Total Liabilities	229.03	194.7	235.74	155.06	361.86
Common Stock	4.86	4.86	5.46	5.46	5.44
Additional Paid-In Capital	290.26	290.26	290.26	289.62	289.3
Retained Earnings	-77.23	32.49	83.82	149.52	199.87
Treasury Stock	-41.15	-46.86	-44.63	-26.49	-
Comprehensive Income & Other	135.34	133.96	129.15	124.12	98.9
Total Common Equity	312.07	414.71	464.07	542.22	593.52
Minority Interest	-6.4	-6.77	-5.84	5.37	-9.37
Shareholders' Equity	305.68	407.93	458.23	547.59	584.15
Total Liabilities & Equity	534.71	602.64	693.97	702.65	946.01
Total Debt	203.26	165.58	135.5	46.87	52.75
Net Cash (Debt)	85.46	213.11	191.64	303.22	412.96
Net Cash Growth	-59.90%	11.20%	-36.80%	-26.57%	26.19%
Net Cash Per Share	0.36	0.83	0.69	1.06	1.44
Filing Date Shares Outstanding	237.16	240.19	270.21	278.46	287.84
Total Common Shares Outstanding	237.16	239.42	271.85	278.57	287.8
Working Capital	258.71	344.87	295.83	289.31	275.67
Book Value Per Share	1.32	1.73	1.71	1.95	2.06
Tangible Book Value	311.47	414.11	463.16	541.39	592.53
Tangible Book Value Per Share	1.31	1.73	1.70	1.94	2.06
Machinery	-	4.75	7.35	16.27	14.51
Construction In Progress	-	-	0	2.8	8.12
Leasehold Improvements	-	15.17	15.17	23.96	18.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.